Johnson & Johnson sees solid growth in all sectors
This article was originally published in Clinica
Executive Summary
Broadly based growth across product sectors and geographic regions drove second-quarter sales for Johnson & Johnson, which were a record $6.9 billion, up 19%, with a 14% rise in net income to $1.2 billion.